Black Friday Deal: $15 OFF Forever on All Plans — Limited Time Only!
NUVA logo
NASDAQ · NUVAMedical - DevicesUpdated Not supplied

NuVasive, Inc. P/E ratio

Current valuation, historical context, and peer comparisons.

Current P/E ratio

75.00×

21.3% belowthe 7-observation annual average

Share price39.75
÷
Earnings per share0.53

Price and EPS in quote currency. Calculation details

Investors are paying 75.00 for every 1 of reported earnings per share.

P/E over time

2013 – 2022
Annual P/ESelected-period average 95.29×
3-year average52.87×1 positive annual observations
5-year average106.92×3 positive annual observations
10-year average95.29×7 positive annual observations
Peer median · TTM26.76×1 peers with positive P/E

Historical P/E ratios

Annual period-end data · 19 observations

NUVA annual P/E history, newest first
Period endP/EChange
Dec 31, 202252.87×N/M
Dec 31, 2021N/MN/M
Dec 31, 2020N/MN/M
Dec 31, 201961.38×-70.3%
Dec 31, 2018206.50×+475.5%
Dec 31, 201735.88×-60.6%
Dec 31, 201691.03×+128.8%
Dec 31, 201539.79×N/M
View all 19 annual observations +
NUVA annual P/E history, newest first
Period endP/EChange
Dec 31, 2014N/MN/M
Dec 31, 2013179.61×-18.7%
Dec 31, 2012220.86×N/M
Dec 31, 2011N/MN/M
Dec 31, 201012.89×-93.6%
Dec 31, 2009199.88×N/M
Dec 31, 2008N/MN/M
Dec 31, 2007N/MN/M
Dec 31, 2006N/MN/M
Dec 31, 2005N/MN/M
Dec 31, 2004N/MN/M

Change is relative to the preceding observation. N/M values are excluded from averages.

How NUVA compares

Company P/E vs. peer trailing-12-month ratios

P/E comparison with NUVA and provider-selected peers
CompanyP/E ratio
NUVA logo
NUVA This stockNuVasive, Inc.
75.00×
ASTH logo
ASTHAstrana Health, Inc.
26.76×
CALT logo
CALTCalliditas Therapeutics AB (publ)
N/M
AMAM logo
AMAMAmbrx Biopharma Inc.
N/M
DCPH logo
DCPHDeciphera Pharmaceuticals, Inc.
N/M
DICE logo
DICEDICE Therapeutics, Inc.
N/M
FUSN logo
FUSNFusion Pharmaceuticals Inc.
N/M
BLU logo
BLUBELLUS Health Inc.
N/M
LBPH logo
LBPHLongboard Pharmaceuticals, Inc.
N/M

Peers are selected by the data provider. Business models and earnings definitions can differ.

Put the numbers in context

What does NUVA’s P/E tell you?

01

Start with its own history

At 75.00×, NUVA is 21.3% below its 7-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

02

Compare like with like

The median of the 1 positive peer ratios above is 26.76×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.

03

Check what drives earnings

One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.

Keep your research connected

Take NUVA into your spreadsheet

Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.

Explore Wisesheets
Quarterly P/E · latest quarter
=WISE("NUVA", "PE Ratio", "LQ")
LQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data

Sources & calculation methodology

Current P/E

Share price 39.75 ÷ EPS 0.53 = 75.00×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Not supplied; this is not a real-time trading quote.

History & averages

Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.

Data definitions and limitations

The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.

NUVA P/E ratio: common questions

The essentials behind the numbers.

NuVasive, Inc.'s current P/E is 75.00× based on the quote data last updated Not supplied. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.